Clinical trial NCT05319652: Feasibility Study of an Online Self-management Program for Chronic Non-cancer Pain
Official title: Co-development and Assessment of the Feasibility and Potential Effects of an Online Self-management Program for Chronic Non-cancer Pain
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Chronic Pain
Lead sponsor: CHU de Quebec-Universite Laval
Sponsor class: OTHER
First posted: 2022-04-08
Enrollment: 63
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: Based on a mixed-methods design, the objective of this trial is to assess the feasibility and acceptability of the "Agir pour moi" program, an 8-week online self-management program for chronic non-cancer pain (CNCP). The investigators will also explore its potential effects on self-efficacy, pain interference, pain severity, anxiety, depression, catastrophizing, and global impression of change in adults with CNCP awaiting services from a chronic pain multidisciplinary treatment center.

Detailed description: The mixed-methods sequential explanatory design combines a quantitative questionnaire-based study with a subsequent in depth qualitative approach.

Eligibility criteria: Inclusion Criteria:

* Age ≥ 18 years;
* live with CNCP for more than 3 months;
* read and understand French easily;
* have access to a computer and high-speed Internet;
* be available to take part in the project for 6 to 8 months;
* not having started a new treatment for pain within the last month;
* agree to notify the team before starting a new treatment;
* be able to give informed consent.

Exclusion Criteria:

* be supported by a multidisciplinary treatment center or be likely to be in the short term;
* having participated in a CNCP self-management program within the last year;
* be awaiting scheduled surgical treatment within six months.

Primary outcomes:
measure: Feasibility of the recruitment
timeFrame: Baseline
measure: Feasibility of data collection
timeFrame: Baseline
measure: Feasibility of data collection
timeFrame: Post-intervention (8 weeks)
measure: Feasibility of data collection
timeFrame: 3 months post-intervention
measure: Acceptability
timeFrame: Post-intervention (8 Weeks)
measure: Acceptability
timeFrame: 4 months post-intervention
measure: Adherence to the program
timeFrame: Post-intervention (8 weeks)
Secondary outcomes:
measure: Change in self-efficacy: French version of the Pain Self-Efficacy Questionnaire (PSEQ)
timeFrame: Baseline; Post-intervention (8 weeks); 3 months post-intervention
measure: Change in pain severity and pain interference: French version of the Brief Pain Inventory (BPI)
timeFrame: Baseline; Post-intervention (8 weeks); 3 months post-intervention
measure: Change in anxiety and depression: French version of the Hospital Anxiety and Depression Scale (HADS)
timeFrame: Baseline; Post-intervention (8 weeks); 3 months post-intervention
measure: Change in pain catastrophizing: French version of the Pain Catastrophizing Scale (PCS)
timeFrame: Baseline; Post-intervention (8 weeks); 3 months post-intervention
measure: Patient Global Impression of Change Scale (PGIC)
timeFrame: Post-intervention (8 weeks); 3 months post-intervention
Other outcomes:
Locations:
city: Québec
country: Canada
facility: CHU de Québec
state: Quebec
Study officials:
affiliation: CHU de Quebec-Universite Laval
name: Anne Marie Pinard, MD, M(Ed.)
role: PRINCIPAL_INVESTIGATOR
References: